Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Invested Capital (2019 - 2025)

AVITA Medical's Invested Capital history spans 7 years, with the latest figure at $26.3 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 485.33% year-over-year to $26.3 million; the TTM value through Dec 2025 reached $26.3 million, up 485.33%, while the annual FY2025 figure was $26.3 million, 485.33% up from the prior year.
  • Invested Capital reached $26.3 million in Q4 2025 per RCEL's latest filing, down from $35.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $118.9 million in Q1 2021 to a low of -$9.9 million in Q2 2025.
  • Average Invested Capital over 5 years is $59.8 million, with a median of $65.8 million recorded in 2023.
  • The largest YoY upside for Invested Capital was 485.33% in 2025 against a maximum downside of 141.36% in 2025.
  • A 5-year view of Invested Capital shows it stood at $104.6 million in 2021, then decreased by 19.01% to $84.7 million in 2022, then tumbled by 42.11% to $49.1 million in 2023, then plummeted by 90.83% to $4.5 million in 2024, then soared by 485.33% to $26.3 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Invested Capital are $26.3 million (Q4 2025), $35.8 million (Q3 2025), and -$9.9 million (Q2 2025).